commit 4a84d9e90bb507ce17a52f782689062056a98175
Author: davidlagorce <david.lagorce@inserm.fr>
Date:   Tue Jul 2 21:30:06 2024 +0200

    JULY 2024

diff --git a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml
index f024277..b40a202 100644
--- a/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
+++ b/Epidemiological data/Rare disease epidemiology/nl_product9_prev.xml	
@@ -1,5 +1,5 @@
 <?xml version="1.0" encoding="ISO-8859-1"?>
-<JDBOR date="2023-12-04 08:24:16" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2023" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
+<JDBOR date="2024-07-01 09:43:58" version="1.3.29 / 4.1.7 [2023-08-02] (orientdb version)" copyright="Orphanet (c) 2024" dbserver="jdbc:sybase:Tds:canard.orpha.net:2020">
   <Availability> 
     <Licence>
       <FullName lang="en">Creative Commons Attribution 4.0 International</FullName>
@@ -7,11 +7,11 @@
       <LegalCode>https://creativecommons.org/licenses/by/4.0/legalcode</LegalCode>
     </Licence>
   </Availability>
-  <DisorderList count="6088">
+  <DisorderList count="6076">
     <Disorder id="17601">
       <OrphaCode>166024</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166024</ExpertLink>
-      <Name lang="nl">Multipele epifysaire dysplasie, Al-Gazali-type</Name>
+      <Name lang="nl">Multipele epifysaire dysplasie - macrocefalie - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -111,7 +111,7 @@
     <Disorder id="17603">
       <OrphaCode>166032</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166032</ExpertLink>
-      <Name lang="nl">Multipele epifysaire dysplasie met mini-epifysen</Name>
+      <Name lang="nl">Multipele epifysaire dysplasie - mini-epifysen-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -306,7 +306,7 @@
     <Disorder id="17602">
       <OrphaCode>166029</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166029</ExpertLink>
-      <Name lang="nl">Multipele epifysaire dysplasie met ernstige proximale femorale dysplasie</Name>
+      <Name lang="nl">Multipele epifysaire dysplasie - ernstige proximale femorale dysplasie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -568,17 +568,17 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="13">
-          <Source>36980153[PMID]_37732042[PMID]_ORPHANET</Source>
+          <Source>33144036[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
           </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
+          <ValMoy>0.2</ValMoy>
           <PrevalenceGeographic id="23844">
             <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
@@ -12133,55 +12133,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17598">
-      <OrphaCode>166011</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=166011</ExpertLink>
-      <Name lang="nl">Multipele epifysaire dysplasie, Beighton-type</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8320">
-          <Source>699354[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Family</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8321">
-          <Source>ORPHANET_699354[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="126">
       <OrphaCode>567</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=567</ExpertLink>
@@ -15957,7 +15908,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="10703">
           <Source>19289752[PMID]</Source>
           <PrevalenceType id="23676">
@@ -15977,6 +15928,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17561">
+          <Source>32141953[PMID]_35359921[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.4805</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="158">
@@ -16186,7 +16156,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="581">
           <Source>12088082[PMID]</Source>
           <PrevalenceType id="23683">
@@ -16225,6 +16195,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17537">
+          <Source>12088082[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>13.3</ValMoy>
+          <PrevalenceGeographic id="25006">
+            <Name lang="nl">Norway</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17538">
+          <Source>14967851[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.2</ValMoy>
+          <PrevalenceGeographic id="24537">
+            <Name lang="nl">Hong Kong</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="147">
@@ -17074,7 +17082,7 @@
     <Disorder id="17514">
       <OrphaCode>163649</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=163649</ExpertLink>
-      <Name lang="nl">Spondylo-epifysaire dysplasie, Nishimura-type</Name>
+      <Name lang="nl">Spondylo-epifysaire dysplasie - craniosynostose - gespleten gehemelte - cataract - intellectuele achterstand-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -17243,7 +17251,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
+      <PrevalenceList count="5">
         <Prevalence id="637">
           <Source>11949733[PMID]_[EXPERT]</Source>
           <PrevalenceType id="23676">
@@ -17320,6 +17328,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17511">
+          <Source>9724012[PMID]_11949733[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.8</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="168">
@@ -17569,7 +17596,7 @@
     <Disorder id="173">
       <OrphaCode>394</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=394</ExpertLink>
-      <Name lang="nl">Klassieke homocystinurie</Name>
+      <Name lang="nl">Homocystinurie door deficiëntie van cystathionine-bèta-synthase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -18513,7 +18540,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="8297">
           <Source>PMID: 22911482</Source>
           <PrevalenceType id="23676">
@@ -18533,6 +18560,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17565">
+          <Source>28898171[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="nl">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="190">
@@ -23959,7 +24005,7 @@
     <Disorder id="257">
       <OrphaCode>1646</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1646</ExpertLink>
-      <Name lang="nl">Partiële deletie van chromosoom Y</Name>
+      <Name lang="nl">Chromosoom Y-microdeletie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -25532,8 +25578,8 @@
       <OrphaCode>308</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=308</ExpertLink>
       <Name lang="nl">Progressieve myoclonische epilepsie type 1</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -29265,7 +29311,7 @@
     <Disorder id="367">
       <OrphaCode>610</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=610</ExpertLink>
-      <Name lang="nl">Bethlem-myopathie</Name>
+      <Name lang="nl">Spierdystrofie van Bethlem</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -31221,38 +31267,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="444">
-      <OrphaCode>1455</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1455</ExpertLink>
-      <Name lang="nl">Autosomaal dominante coarctatie van aorta</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="1105">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17788">
       <OrphaCode>168624</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168624</ExpertLink>
@@ -33011,277 +33025,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17765">
-      <OrphaCode>168486</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168486</ExpertLink>
-      <Name lang="nl">Congenitale neuronale ceroïdlipofuscinose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="8367">
-          <Source>16670177[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>10.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8368">
-          <Source>ORPHANET_16670177[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="17766">
-      <OrphaCode>168491</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168491</ExpertLink>
-      <Name lang="nl">Laat-infantiele neuronale ceroïdlipofuscinose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="11">
-        <Prevalence id="8369">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8370">
-          <Source>1609834[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.46</ValMoy>
-          <PrevalenceGeographic id="24418">
-            <Name lang="nl">Germany</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8371">
-          <Source>23374165[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.78</ValMoy>
-          <PrevalenceGeographic id="24607">
-            <Name lang="nl">Italy</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8372">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8373">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.26</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8374">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8375">
-          <Source>9151309[PMID]_[EXPERT]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.06</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8376">
-          <Source>18684116[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>9.0</ValMoy>
-          <PrevalenceGeographic id="24124">
-            <Name lang="nl">Canada</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="8377">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10739">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.07</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10740">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.38</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="nl">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17767">
       <OrphaCode>168544</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=168544</ExpertLink>
@@ -40468,7 +40211,7 @@
     <Disorder id="530">
       <OrphaCode>2374</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2374</ExpertLink>
-      <Name lang="nl">Congenitaal web van larynx</Name>
+      <Name lang="nl">Geïsoleerd congenitaal web van larynx</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -44543,7 +44286,7 @@
     <Disorder id="578">
       <OrphaCode>834</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=834</ExpertLink>
-      <Name lang="nl">Vrij siaalzuurstapelingsziekte</Name>
+      <Name lang="nl">Vrij-siaalzuurstapelingsziekte</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -46190,7 +45933,7 @@
     <Disorder id="606">
       <OrphaCode>1422</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1422</ExpertLink>
-      <Name lang="nl">Chondrodysplasie - geslachtsontwikkelingsstoornis-syndroom</Name>
+      <Name lang="nl">Chondrodysplasie - variatie in geslachtelijke ontwikkeling-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -50280,7 +50023,7 @@
     <Disorder id="17999">
       <OrphaCode>178029</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=178029</ExpertLink>
-      <Name lang="nl">Centrale diabetes insipidus</Name>
+      <Name lang="nl">Deficiëntie van arginine-vasopressine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -53879,9 +53622,9 @@
     <Disorder id="751">
       <OrphaCode>2406</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2406</ExpertLink>
-      <Name lang="nl">Locked-in-syndroom</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <Name lang="nl">Locked-in syndroom</Name>
+      <DisorderType id="21422">
+        <Name lang="nl">Klinisch syndroom</Name>
       </DisorderType>
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
@@ -67248,7 +66991,7 @@
     <Disorder id="771">
       <OrphaCode>13</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=13</ExpertLink>
-      <Name lang="nl">Deficiëntie van 6-pyruvoyl-tetrahydropterine-synthase</Name>
+      <Name lang="nl">Deficiëntie van 6-pyruvoyl-tetrahydropterinesynthase</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -70023,7 +69766,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="20">
+      <PrevalenceList count="21">
         <Prevalence id="2360">
           <Source>28595941[PMID]</Source>
           <PrevalenceType id="23683">
@@ -70233,6 +69976,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17512">
+          <Source>18681890[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>27.6</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13922">
           <Source>28595941[PMID]</Source>
           <PrevalenceType id="23683">
@@ -75358,7 +75120,7 @@
     <Disorder id="18311">
       <OrphaCode>183707</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=183707</ExpertLink>
-      <Name lang="nl">Neutrofiel immuundeficiëntiesyndroom</Name>
+      <Name lang="nl">Infantiele LAD-achtige ziekte door RAC2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -75407,7 +75169,7 @@
     <Disorder id="839">
       <OrphaCode>2314</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2314</ExpertLink>
-      <Name lang="nl">Autosomaal dominant hyper-IgE-syndroom</Name>
+      <Name lang="nl">Autosomaal dominant hyper-IgE-syndroom door STAT3-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -77876,7 +77638,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17517">
+          <Source>[https://www.ncbi.nlm.nih.gov/books/NBK1760/]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>3.0E-4</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17459">
           <Source>[https://www.ncbi.nlm.nih.gov/books/NBK1760/]_ORPHANET</Source>
           <PrevalenceType id="23683">
@@ -78990,7 +78771,7 @@
     <Disorder id="900">
       <OrphaCode>847</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=847</ExpertLink>
-      <Name lang="nl">Alfa-thalassemie - X-gebonden intellectuele achterstand-syndroom</Name>
+      <Name lang="nl">X-gebonden alfa-thalassemie - intellectuele achterstand-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -84978,7 +84759,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17549">
+          <Source>7977461[PMID]_37868647[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.1</ValMoy>
+          <PrevalenceGeographic id="25293">
+            <Name lang="nl">Spain</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13319">
           <Source>7977461[PMID]</Source>
           <PrevalenceType id="23683">
@@ -85444,7 +85244,7 @@
     <Disorder id="1255">
       <OrphaCode>931</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=931</ExpertLink>
-      <Name lang="nl">Acheiropodie</Name>
+      <Name lang="nl">Geïsoleerde acheiropodie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -89249,7 +89049,7 @@
     <Disorder id="1293">
       <OrphaCode>973</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=973</ExpertLink>
-      <Name lang="nl">Congenitale unilaterale afwezigheid/hypoplasie van vingers exclusief duim</Name>
+      <Name lang="nl">Geïsoleerde afwezigheid/hypoplasie van vingers exclusief duim, unilateraal</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -89762,7 +89562,7 @@
     <Disorder id="16894">
       <OrphaCode>139431</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139431</ExpertLink>
-      <Name lang="nl">Syndroom van Jeavons</Name>
+      <Name lang="nl">Epilepsie met myoclonie van ooglid</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -90068,38 +89868,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="16886">
-      <OrphaCode>139402</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139402</ExpertLink>
-      <Name lang="nl">Reactie op medicatie met eosinofilie en systemische symptomen</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="8128">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1335">
       <OrphaCode>1027</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1027</ExpertLink>
@@ -90149,6 +89917,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="16886">
+      <OrphaCode>139402</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139402</ExpertLink>
+      <Name lang="nl">Reactie op medicatie met eosinofilie en systemische symptomen</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="8128">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="nl">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="16887">
       <OrphaCode>139406</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=139406</ExpertLink>
@@ -91413,7 +91213,7 @@
     <Disorder id="1481">
       <OrphaCode>115</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=115</ExpertLink>
-      <Name lang="nl">Congenitale contracturale arachnodactylie</Name>
+      <Name lang="nl">Congenitale contracturele arachnodactylie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -92570,19 +92370,19 @@
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8056">
-          <Source>European Medicines Agency[INST]</Source>
+          <Source>32732703[PMID]_34622738[PMID]_33607690[PMID]_3391390{PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass id="23732">
-            <Name lang="nl">1-5 / 10 000</Name>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
           </PrevalenceClass>
-          <ValMoy>16.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
+          <ValMoy>4.2091</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
           </PrevalenceGeographic>
           <PrevalenceValidationStatus id="25958">
             <Name lang="nl">Validated</Name>
@@ -95894,7 +95694,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="2971">
           <Source>9714114[PMID]</Source>
           <PrevalenceType id="23683">
@@ -95933,6 +95733,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17539">
+          <Source>9714114[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17540">
+          <Source>11515692[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25335">
+            <Name lang="nl">Sweden</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="1642">
@@ -96865,7 +96703,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17562">
+          <Source>32670090[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24362">
+            <Name lang="nl">Finland</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13947">
           <Source>16892327[PMID]</Source>
           <PrevalenceType id="23683">
@@ -96936,104 +96793,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="17078">
-      <OrphaCode>141327</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=141327</ExpertLink>
-      <Name lang="nl">Orofaciodigitaal syndroom type 12</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13442">
-          <Source>9546832[PMID]_17963220[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13443">
-          <Source>ORPHANET_9546832[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="17079">
-      <OrphaCode>141330</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=141330</ExpertLink>
-      <Name lang="nl">Orofaciodigitaal syndroom type 13</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13444">
-          <Source>10683749[PMID]_17963220[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13445">
-          <Source>ORPHANET_10683749[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1654">
       <OrphaCode>1471</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1471</ExpertLink>
@@ -97581,7 +97340,26 @@
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17523">
+          <Source>21701667[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0017</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12871">
           <Source>ORPHANET_21701667[PMID]</Source>
           <PrevalenceType id="23683">
@@ -97839,7 +97617,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17558">
+          <Source>16410137[PMID]_30159250[PMID]_32851317[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="nl">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14484">
           <Source>17712567[PMID]</Source>
           <PrevalenceType id="23683">
@@ -97979,7 +97776,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17559">
+          <Source>ISBN-10:0867153903[OTHER]_28163490[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.16</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13324">
           <Source>ISBN-10:0867153903[OTHER]_28163490[PMID]</Source>
           <PrevalenceType id="23683">
@@ -100254,55 +100070,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1776">
-      <OrphaCode>1765</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1765</ExpertLink>
-      <Name lang="nl">Dyschondrosteose - nefritis-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3244">
-          <Source>788812[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23725">
-            <Name lang="nl">Family</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>1.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3245">
-          <Source>ORPHANET_788812[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="1777">
       <OrphaCode>1766</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1766</ExpertLink>
@@ -101418,12 +101185,12 @@
     <Disorder id="1739">
       <OrphaCode>1617</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1617</ExpertLink>
-      <Name lang="nl">2q24-microdeletiesyndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <Name lang="nl">Ontwikkelingsachterstand - taalstoornis - doparesponsieve dystonie - parkinsonisme-syndroom door 2q24-microdeletie</Name>
+      <DisorderType id="21443">
+        <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="3221">
@@ -101474,7 +101241,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="3219">
           <Source>9326330[PMID]</Source>
           <PrevalenceType id="23683">
@@ -101494,6 +101261,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17550">
+          <Source>9326330[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="16907">
@@ -103794,55 +103580,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="1715">
-      <OrphaCode>1562</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1562</ExpertLink>
-      <Name lang="nl">Dacryocystitis - osteopoikilose-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3194">
-          <Source>8261652[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3195">
-          <Source>ORPHANET_8261652[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="17010">
       <OrphaCode>140963</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=140963</ExpertLink>
@@ -106361,7 +106098,7 @@
     <Disorder id="1880">
       <OrphaCode>1917</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1917</ExpertLink>
-      <Name lang="nl">Foetaal syndroom door methylkwik</Name>
+      <Name lang="nl">Foetaal methylkwiksyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -108058,7 +107795,7 @@
     <Disorder id="1816">
       <OrphaCode>1837</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1837</ExpertLink>
-      <Name lang="nl">Metafysaire dysplasie van ulna-syndroom</Name>
+      <Name lang="nl">Metafysaire chondrodysplasie, Rosenberg-type</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -108627,7 +108364,7 @@
     <Disorder id="1794">
       <OrphaCode>1798</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1798</ExpertLink>
-      <Name lang="nl">Dysostose, Stanescu-type</Name>
+      <Name lang="nl">Craniofaciale dysostose - diafysaire hyperplasie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -108635,7 +108372,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="3259">
+        <Prevalence id="17480">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -108757,7 +108494,7 @@
     <Disorder id="2035">
       <OrphaCode>2130</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2130</ExpertLink>
-      <Name lang="nl">Hemimelie</Name>
+      <Name lang="nl">Niet-syndromale hemimelie</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -110068,7 +109805,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="8254">
           <Source>22969141[PMID]</Source>
           <PrevalenceType id="23676">
@@ -110088,6 +109825,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17560">
+          <Source>22969141[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0225</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="nl">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="2010">
@@ -110174,7 +109930,7 @@
     <Disorder id="2011">
       <OrphaCode>380</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=380</ExpertLink>
-      <Name lang="nl">Cefalopolysyndactyliesyndroom van Greig</Name>
+      <Name lang="nl">Greig-cefalopolysyndactyliesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -119982,7 +119738,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11867">
           <Source>7802035[PMID]</Source>
           <PrevalenceType id="23683">
@@ -120002,6 +119758,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17563">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25293">
+            <Name lang="nl">Spain</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="2061">
@@ -122419,7 +122194,7 @@
     <Disorder id="19611">
       <OrphaCode>251056</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=251056</ExpertLink>
-      <Name lang="nl">6q25-microdeletiesyndroom</Name>
+      <Name lang="nl">6q25.2q25.3-microdeletiesyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -125646,8 +125421,8 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3780">
-          <Source>1068420[PMID]_8030663[PMID]</Source>
+        <Prevalence id="17477">
+          <Source>8030663[PMID]_1068420[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Cases/families</Name>
           </PrevalenceType>
@@ -125663,8 +125438,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3781">
-          <Source>ORPHANET_1068420[PMID]_8030663[PMID]</Source>
+        <Prevalence id="17478">
+          <Source>8030663[PMID]_1068420[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -126111,7 +125886,7 @@
     <Disorder id="2465">
       <OrphaCode>2704</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2704</ExpertLink>
-      <Name lang="nl">Syndroom van Ochoa</Name>
+      <Name lang="nl">Urofaciaal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -126986,7 +126761,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="3825">
+        <Prevalence id="17481">
           <Source>[EXPERT]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Cases/families</Name>
@@ -127003,8 +126778,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="3826">
-          <Source>ORPHANET</Source>
+        <Prevalence id="17482">
+          <Source>[EXPERT]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -127154,55 +126929,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2508">
-      <OrphaCode>2752</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2752</ExpertLink>
-      <Name lang="nl">Orofaciodigitaal syndroom type 3</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="3819">
-          <Source>5004413[PMID]_8230165[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="3820">
-          <Source>ORPHANET_5004413[PMID]_8230165[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2507">
       <OrphaCode>2751</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2751</ExpertLink>
@@ -128036,7 +127762,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
-        <Prevalence id="3829">
+        <Prevalence id="17479">
           <Source>ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
@@ -130765,7 +130491,7 @@
     <Disorder id="2309">
       <OrphaCode>2497</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2497</ExpertLink>
-      <Name lang="nl">Mesomele dysplasie van bovenste ledematen</Name>
+      <Name lang="nl">Mesomele dysplasie van bovenste ledematen, Fryns-type</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -134840,38 +134566,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2421">
-      <OrphaCode>2646</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2646</ExpertLink>
-      <Name lang="nl">Parastremmatische dwerggroei</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="3759">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2420">
       <OrphaCode>2645</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2645</ExpertLink>
@@ -136067,11 +135761,11 @@
       <OrphaCode>263516</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=263516</ExpertLink>
       <Name lang="nl">Progressieve myoclonische epilepsie type 3</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="9327">
@@ -136690,7 +136384,7 @@
     <Disorder id="2713">
       <OrphaCode>1832</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1832</ExpertLink>
-      <Name lang="nl">Letale osteosclerotische botdysplasie</Name>
+      <Name lang="nl">Osteosclerotische botdysplasie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -138270,7 +137964,7 @@
     <Disorder id="2814">
       <OrphaCode>3145</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3145</ExpertLink>
-      <Name lang="nl">Nefrogene diabetes insipidus - intracraniële calcificatie - kleine gestalte - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Resistentie voor arginine-vasopressine - intracraniële calcificatie - kleine gestalte - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -139769,55 +139463,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2609">
-      <OrphaCode>2878</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2878</ExpertLink>
-      <Name lang="nl">Focomelie - ectrodactylie - doofheid - sinusaritmie-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="12754">
-          <Source>7077621[PMID]_4447434[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>4.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="12755">
-          <Source>ORPHANET_7077621[PMID]_4447434[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20208">
       <OrphaCode>268826</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=268826</ExpertLink>
@@ -140339,7 +139984,7 @@
     <Disorder id="2596">
       <OrphaCode>2863</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2863</ExpertLink>
-      <Name lang="nl">Kleine gestalte - wormvormige botten - dextrocardie-syndroom</Name>
+      <Name lang="nl">Kleine gestalte - Wormiaanse botstructuren - dextrocardie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -147093,7 +146738,7 @@
     <Disorder id="2997">
       <OrphaCode>3384</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3384</ExpertLink>
-      <Name lang="nl">Truncus arteriosus</Name>
+      <Name lang="nl">Truncus arteriosus communis</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -148789,7 +148434,7 @@
     <Disorder id="20315">
       <OrphaCode>275517</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=275517</ExpertLink>
-      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom met recidiverende virale infecties</Name>
+      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom met recidiverende virale infecties door CASP8-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -149132,7 +148777,7 @@
     <Disorder id="2962">
       <OrphaCode>3339</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3339</ExpertLink>
-      <Name lang="nl">Syndroom van Toriello-Lacassie-Droste</Name>
+      <Name lang="nl">Oculo-ectodermaal syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -149181,12 +148826,12 @@
     <Disorder id="20307">
       <OrphaCode>271861</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=271861</ExpertLink>
-      <Name lang="nl">Erfelijke ATTR-amyloïdose</Name>
-      <DisorderType id="21436">
-        <Name lang="nl">Group of phenomes</Name>
+      <Name lang="nl">Hereditaire ATTR-amyloïdose</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
       </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="nl">Groep van aandoeningen</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="41">
         <Prevalence id="17308">
@@ -153009,55 +152654,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2865">
-      <OrphaCode>3210</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3210</ExpertLink>
-      <Name lang="nl">Syndroom van Summitt</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4092">
-          <Source>474616[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4093">
-          <Source>ORPHANET_474616[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="2864">
       <OrphaCode>3201</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3201</ExpertLink>
@@ -155372,7 +154968,7 @@
     <Disorder id="2916">
       <OrphaCode>3265</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3265</ExpertLink>
-      <Name lang="nl">Humeroradiale synostose</Name>
+      <Name lang="nl">Geïsoleerde humeroradiale synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -155453,7 +155049,7 @@
     <Disorder id="2917">
       <OrphaCode>3266</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3266</ExpertLink>
-      <Name lang="nl">Humeroradio-ulnaire synostose</Name>
+      <Name lang="nl">Geïsoleerde humeroradio-ulnaire synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -156409,55 +156005,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="2883">
-      <OrphaCode>3226</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3226</ExpertLink>
-      <Name lang="nl">Doofheid - lymfoedeem - leukemie-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4104">
-          <Source>ORPHANET_21892158[PMID]_20803646[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>20.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4105">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="20353">
       <OrphaCode>276183</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=276183</ExpertLink>
@@ -157484,7 +157031,7 @@
     <Disorder id="2905">
       <OrphaCode>3248</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3248</ExpertLink>
-      <Name lang="nl">Distaal symfalangisme</Name>
+      <Name lang="nl">Geïsoleerd distaal symfalangisme</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -160771,55 +160318,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3238">
-      <OrphaCode>2729</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2729</ExpertLink>
-      <Name lang="nl">Syndroom van Okamoto</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4346">
-          <Source>20179579[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4347">
-          <Source>ORPHANET_20179579[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3243">
       <OrphaCode>65</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65</ExpertLink>
@@ -161379,38 +160877,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3165">
-      <OrphaCode>2756</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2756</ExpertLink>
-      <Name lang="nl">Orofaciodigitaal syndroom type 10</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="4307">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3167">
       <OrphaCode>2326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2326</ExpertLink>
@@ -161716,7 +161182,7 @@
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
-        <Prevalence id="4295">
+        <Prevalence id="17495">
           <Source>25485486[PMID]_28235247[PMID]</Source>
           <PrevalenceType id="23697">
             <Name lang="nl">Cases/families</Name>
@@ -161733,8 +161199,8 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
-        <Prevalence id="4296">
-          <Source>ORPHANET_25485486[PMID]_28235247[PMID]</Source>
+        <Prevalence id="17496">
+          <Source>25485486[PMID]_28235247[PMID]_ORPHANET</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
@@ -162758,7 +162224,7 @@
     <Disorder id="3096">
       <OrphaCode>1415</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1415</ExpertLink>
-      <Name lang="nl">Cholestase - pigmentretinopathie - gespleten gehemelte-syndroom</Name>
+      <Name lang="nl">Syndroom van Hardikar</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -162804,55 +162270,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3103">
-      <OrphaCode>2653</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2653</ExpertLink>
-      <Name lang="nl">Osteochondrodysplastisch nanisme - doofheid - retinitis pigmentosa-syndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="4272">
-          <Source>2783003[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="4273">
-          <Source>ORPHANET_2783003[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="18654">
       <OrphaCode>209335</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=209335</ExpertLink>
@@ -173194,7 +172611,7 @@
     <Disorder id="3489">
       <OrphaCode>3269</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3269</ExpertLink>
-      <Name lang="nl">Congenitale radio-ulnaire synostose</Name>
+      <Name lang="nl">Geïsoleerde radio-ulnaire synostose</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -173759,6 +173176,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="18790">
+      <OrphaCode>216729</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=216729</ExpertLink>
+      <Name lang="nl">Congenitaal niet-gecorrigeerde transpositie van grote slagaders met hartmalformatie</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
+      </DisorderType>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="8746">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25965">
+            <Name lang="nl">Not yet validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="3495">
       <OrphaCode>3411</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=3411</ExpertLink>
@@ -173808,38 +173257,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="18790">
-      <OrphaCode>216729</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=216729</ExpertLink>
-      <Name lang="nl">Congenitaal niet-gecorrigeerde transpositie van grote slagaders met hartmalformatie</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
-      </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="8746">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3494">
       <OrphaCode>882</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=882</ExpertLink>
@@ -175594,7 +175011,7 @@
     <Disorder id="3399">
       <OrphaCode>2330</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2330</ExpertLink>
-      <Name lang="nl">Syndroom van Kasabach-Merritt</Name>
+      <Name lang="nl">Fenomeen van Kasabach-Merritt</Name>
       <DisorderType id="21429">
         <Name lang="nl">Particulaire klinische situatie binnen een ziekte of syndroom</Name>
       </DisorderType>
@@ -175822,7 +175239,7 @@
     <Disorder id="18818">
       <OrphaCode>217059</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=217059</ExpertLink>
-      <Name lang="nl">Geïsoleerde congenitale trommelstokvingers</Name>
+      <Name lang="nl">Geïsoleerde horlogeglasnagel</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -176305,38 +175722,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="3413">
-      <OrphaCode>344</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=344</ExpertLink>
-      <Name lang="nl">Koorts door arbovirus</Name>
-      <DisorderType id="36561">
-        <Name lang="nl">Categorie</Name>
-      </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="nl">Groep van aandoeningen</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="4535">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="3412">
       <OrphaCode>341</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=341</ExpertLink>
@@ -177042,12 +176427,12 @@
     <Disorder id="3434">
       <OrphaCode>1456</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1456</ExpertLink>
-      <Name lang="nl">Atypische coarctatie van aorta</Name>
-      <DisorderType id="21450">
-        <Name lang="nl">Klinisch subtype</Name>
+      <Name lang="nl">Mid-aorta syndroom</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
-      <DisorderGroup id="36554">
-        <Name lang="nl">Subtype van aandoening</Name>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="4551">
@@ -179446,7 +178831,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17551">
+          <Source>17570073[PMID]_21123949[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23851">
+            <Name lang="nl">Specifieke populatie</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12575">
           <Source>17570073[PMID]_21123949[PMID]</Source>
           <PrevalenceType id="23683">
@@ -180291,7 +179695,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="4">
+      <PrevalenceList count="5">
         <Prevalence id="4500">
           <Source>19650784[PMID]</Source>
           <PrevalenceType id="23669">
@@ -180368,6 +179772,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17513">
+          <Source>16968795[PMID]_ 19650784[PMID]_ 19968031[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>50.7</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="18939">
@@ -185785,7 +185208,7 @@
     <Disorder id="3726">
       <OrphaCode>223</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=223</ExpertLink>
-      <Name lang="nl">Nefrogene diabetes insipidus</Name>
+      <Name lang="nl">Resistentie voor arginine-vasopressine</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -185885,7 +185308,7 @@
     <Disorder id="19131">
       <OrphaCode>228423</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228423</ExpertLink>
-      <Name lang="nl">Monocytopenie met susceptibiliteit voor infecties</Name>
+      <Name lang="nl">GATA2-deficiëntie-spectrum</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -186091,7 +185514,7 @@
     <Disorder id="3704">
       <OrphaCode>132</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=132</ExpertLink>
-      <Name lang="nl">Deficiëntie van butyrylcholinesterase</Name>
+      <Name lang="nl">Hereditaire deficiëntie van butyrylcholinesterase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -186542,7 +185965,7 @@
     <Disorder id="19127">
       <OrphaCode>228410</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228410</ExpertLink>
-      <Name lang="nl">Polyvalvulaire hartziekte-syndroom</Name>
+      <Name lang="nl">Hartanomalieën - kleine gestalte - gewrichtshypermobiliteit - faciale dysmorfie-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -186741,11 +186164,11 @@
       <OrphaCode>228384</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=228384</ExpertLink>
       <Name lang="nl">5q14.3-microdeletiesyndroom</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
+      <DisorderType id="21443">
+        <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="2">
         <Prevalence id="8912">
@@ -189576,7 +188999,7 @@
     <Disorder id="3619">
       <OrphaCode>2841</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=2841</ExpertLink>
-      <Name lang="nl">Familiale goedaardige chronische pemfigus</Name>
+      <Name lang="nl">Ziekte van Hailey-Hailey</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -193210,7 +192633,7 @@
     <Disorder id="19332">
       <OrphaCode>240085</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=240085</ExpertLink>
-      <Name lang="nl">Progressieve supranucleaire paralyse - parkinsonisme-syndroom</Name>
+      <Name lang="nl">Progressieve supranucleaire paralyse - predominant parkinsonisme-syndroom</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -193372,7 +192795,7 @@
     <Disorder id="21992">
       <OrphaCode>331176</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=331176</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door G6PC3-deficiëntie</Name>
+      <Name lang="nl">Ernstige congenitale neutropenie door G6PC3-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -194955,7 +194378,7 @@
     <Disorder id="21935">
       <OrphaCode>329469</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=329469</ExpertLink>
-      <Name lang="nl">Acute megakaryoblastische leukemie zonder Downsyndroom</Name>
+      <Name lang="nl">Acute megakaryoblastische leukemie bij kinderen zonder syndroom van Down</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -200687,7 +200110,7 @@
     <Disorder id="21585">
       <OrphaCode>317476</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=317476</ExpertLink>
-      <Name lang="nl">X-gebonden immuundeficiëntie met magnesiumdefect, infectie door Epstein-Barrvirus en neoplasie</Name>
+      <Name lang="nl">XMEN</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -208649,7 +208072,7 @@
     <Disorder id="22219">
       <OrphaCode>357237</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=357237</ExpertLink>
-      <Name lang="nl">Ernstige gecombineerde immuundeficiëntie door CARD11-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiëntie door CARD11-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -210622,7 +210045,7 @@
     <Disorder id="22129">
       <OrphaCode>353284</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=353284</ExpertLink>
-      <Name lang="nl">Syndroom van Rubinstein-Taybi door haplo-insufficiëntie van EP300</Name>
+      <Name lang="nl">Syndroom van Rubinstein-Taybi door haploinsufficiëntie van EP300</Name>
       <DisorderType id="21443">
         <Name lang="nl">Etiologisch subtype</Name>
       </DisorderType>
@@ -211168,7 +210591,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="9799">
           <Source>18589446[PMID]</Source>
           <PrevalenceType id="23683">
@@ -211188,6 +210611,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17566">
+          <Source>36215864[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>42.4691</ValMoy>
+          <PrevalenceGeographic id="24607">
+            <Name lang="nl">Italy</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="20900">
@@ -212220,7 +211662,7 @@
     <Disorder id="20937">
       <OrphaCode>294975</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=294975</ExpertLink>
-      <Name lang="nl">Congenitale afwezigheid van bovenarm en onderarm met hand aanwezig</Name>
+      <Name lang="nl">Geïsoleerde congenitale afwezigheid van bovenarm en onderarm met hand aanwezig</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -212303,7 +211745,7 @@
     <Disorder id="20935">
       <OrphaCode>294971</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=294971</ExpertLink>
-      <Name lang="nl">Tetra-amelie</Name>
+      <Name lang="nl">Geïsoleerde tetra-amelie</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -212448,7 +211890,7 @@
     <Disorder id="20756">
       <OrphaCode>289661</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=289661</ExpertLink>
-      <Name lang="nl">Epstein-Barrvirus-positief diffuus grootcellig B-cellymfoom bij ouderen</Name>
+      <Name lang="nl">Epstein-Barrvirus-positief diffuus grootcellig B-cellymfoom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -217638,7 +217080,7 @@
     <Disorder id="20592">
       <OrphaCode>284282</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=284282</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom als gevolg van WWOX-deficiëntie</Name>
+      <Name lang="nl">Autosomaal recessieve cerebellaire ataxie - epilepsie - intellectuele achterstand-syndroom door WWOX-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -221387,7 +220829,7 @@
     <Disorder id="21372">
       <OrphaCode>309324</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=309324</ExpertLink>
-      <Name lang="nl">Vrij siaalzuurstapelingsziekte, infantiele vorm</Name>
+      <Name lang="nl">Vrij-siaalzuurstapelingsziekte, infantiele vorm</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -223710,7 +223152,7 @@
     <Disorder id="21236">
       <OrphaCode>306577</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=306577</ExpertLink>
-      <Name lang="nl">Natriumkanalopathie-gerelateerde dunnevezelneuropathie</Name>
+      <Name lang="nl">Hereditaire natriumkanalopathie-gerelateerde dunnevezelneuropathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -226610,7 +226052,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="12112">
           <Source>25976171[PMID]</Source>
           <PrevalenceType id="23683">
@@ -226649,6 +226091,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17524">
+          <Source>22945024[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>2.2</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17543">
+          <Source>25976171[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>4.2</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="nl">Australia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="23660">
@@ -230484,7 +229964,7 @@
     <Disorder id="7030">
       <OrphaCode>1303</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=1303</ExpertLink>
-      <Name lang="nl">Bronchiolitis obliterans met obstructieve longziekte</Name>
+      <Name lang="nl">Bronchiolitis obliterans</Name>
       <DisorderType id="21436">
         <Name lang="nl">Group of phenomes</Name>
       </DisorderType>
@@ -235229,7 +234709,7 @@
     <Disorder id="22919">
       <OrphaCode>404440</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404440</ExpertLink>
-      <Name lang="nl">Intellectuele achterstand - faciale dysmorfie-syndroom door haplo-insufficiëntie van SETD5</Name>
+      <Name lang="nl">Intellectuele achterstand - faciale dysmorfie-syndroom door SETD5-haploinsufficiëntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -235310,7 +234790,7 @@
     <Disorder id="22938">
       <OrphaCode>404553</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=404553</ExpertLink>
-      <Name lang="nl">Vasculitis door ADA2-deficiëntie</Name>
+      <Name lang="nl">Adenosinedeaminase 2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -236805,7 +236285,7 @@
     <Disorder id="22628">
       <OrphaCode>391487</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=391487</ExpertLink>
-      <Name lang="nl">Auto-immune enteropathie en endocrinopathie - vatbaarheid voor chronische infecties-syndroom</Name>
+      <Name lang="nl">STAT1-gerelateerde auto-immune enteropathie en endocrinopathie - susceptibiliteit voor chronische infecties-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -242274,7 +241754,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11292">
           <Source>9061661[PMID]</Source>
           <PrevalenceType id="23683">
@@ -242294,6 +241774,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17567">
+          <Source>30252317[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>5.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="22729">
@@ -243564,7 +243063,7 @@
     <Disorder id="23326">
       <OrphaCode>436141</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=436141</ExpertLink>
-      <Name lang="nl">Ernstige intellectuele achterstand - hypotonie - strabisme - grof gelaat - planovalgus-syndroom</Name>
+      <Name lang="nl">HIDEA-syndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -243760,7 +243259,7 @@
     <Disorder id="23329">
       <OrphaCode>436159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=436159</ExpertLink>
-      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom door haplo-insufficiëntie van CTLA4</Name>
+      <Name lang="nl">Auto-immuun lymfoproliferatief syndroom door CTLA4-haploinsufficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -245015,7 +244514,7 @@
     <Disorder id="23391">
       <OrphaCode>439822</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=439822</ExpertLink>
-      <Name lang="nl">Syndroom door haplo-insufficiëntie van PDE4D</Name>
+      <Name lang="nl">Syndroom door PDE4D-haploinsufficiëntie</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -247108,7 +246607,7 @@
     <Disorder id="23490">
       <OrphaCode>444463</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=444463</ExpertLink>
-      <Name lang="nl">Auto-immune hemolytische anemie - auto-immune trombocytopenie - primaire immuundeficiëntie-syndroom</Name>
+      <Name lang="nl">Auto-immune hemolytische anemie - auto-immune trombocytopenie - primaire immuundeficiëntie-syndroom door TPP2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247355,7 +246854,7 @@
     <Disorder id="23516">
       <OrphaCode>445038</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=445038</ExpertLink>
-      <Name lang="nl">3-methylglutaconacidurie type 7</Name>
+      <Name lang="nl">3-methylglutaconacidurie - neonataal cataract - neurologische betrokkenheid - congenitale neutropenie-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -247502,7 +247001,7 @@
     <Disorder id="23534">
       <OrphaCode>447737</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=447737</ExpertLink>
-      <Name lang="nl">DOCK2-deficiëntie</Name>
+      <Name lang="nl">Gecombineerde immuundeficiëntie door DOCK2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -250461,7 +249960,7 @@
     <Disorder id="23154">
       <OrphaCode>423384</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=423384</ExpertLink>
-      <Name lang="nl">Autosomaal recessieve ernstige congenitale neutropenie door JAGN1-deficiëntie</Name>
+      <Name lang="nl">Ernstige congenitale neutropenie door JAGN1-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -250608,7 +250107,7 @@
     <Disorder id="23160">
       <OrphaCode>423479</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=423479</ExpertLink>
-      <Name lang="nl">X-gebonden intellectuele achterstand - spasticiteit van ledemaat - retinale dystrofie - diabetes insipidus-syndroom</Name>
+      <Name lang="nl">X-gebonden intellectuele achterstand - spasticiteit van ledemaat - retinadystrofie - deficiëntie van arginine-vasopressine-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -264307,7 +263806,7 @@
     <Disorder id="25667">
       <OrphaCode>494344</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=494344</ExpertLink>
-      <Name lang="nl">RERE-gerelateerd neurologisch ontwikkelingssyndroom</Name>
+      <Name lang="nl">RERE-gerelateerd neurologische ontwikkelingssyndroom</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -265264,7 +264763,7 @@
     <Disorder id="8531">
       <OrphaCode>302</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=302</ExpertLink>
-      <Name lang="nl">Epidermodysplasia verruciformis</Name>
+      <Name lang="nl">Hereditaire epidermodysplasia verruciformis</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -267327,7 +266826,7 @@
     <Disorder id="26077">
       <OrphaCode>502430</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=502430</ExpertLink>
-      <Name lang="nl">Metopica-richel - ptosis - faciale dysmorfie-syndroom</Name>
+      <Name lang="nl">Syndroom van Weiss-Kruszka</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -270120,7 +269619,45 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="15">
+      <PrevalenceList count="17">
+        <Prevalence id="17525">
+          <Source>European Centre for Disease prevention and Control 2013-2017[INST]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>1.3</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17527">
+          <Source>CDC Centers for disease Control and prevention 2016[INST]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.7</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13948">
           <Source>CDC Centers for disease Control and prevention 2016[INST]</Source>
           <PrevalenceType id="23683">
@@ -276055,7 +275592,7 @@
     <Disorder id="25364">
       <OrphaCode>487796</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=487796</ExpertLink>
-      <Name lang="nl">Macrotrombocytopenie - lymfoedeem - ontwikkelingsachterstand - faciale dysmorfie - camptodactylie-syndroom</Name>
+      <Name lang="nl">Syndroom van Takenouchi-Kosaki</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -276564,7 +276101,7 @@
     <Disorder id="9283">
       <OrphaCode>30925</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=30925</ExpertLink>
-      <Name lang="nl">Erfelijke centrale diabetes insipidus</Name>
+      <Name lang="nl">Hereditaire deficiëntie van arginine-vasopressine</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -276691,55 +276228,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="25087">
-      <OrphaCode>476102</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=476102</ExpertLink>
-      <Name lang="nl">Erfelijke pediatrische Behçet-achtige ziekte</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="13099">
-          <Source>26642243[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>13.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="13100">
-          <Source>ORPHANET_26642243[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="25085">
       <OrphaCode>476093</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=476093</ExpertLink>
@@ -281827,55 +281315,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="10880">
-      <OrphaCode>65798</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65798</ExpertLink>
-      <Name lang="nl">Syndroom van Goodman</Name>
-      <DisorderType id="21401">
-        <Name lang="nl">Malformatiesyndroom</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="5925">
-          <Source>421359[PMID]</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>3.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="5926">
-          <Source>ORPHANET_421359[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="10865">
       <OrphaCode>65283</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=65283</ExpertLink>
@@ -284120,7 +283559,7 @@
     <Disorder id="10804">
       <OrphaCode>60039</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=60039</ExpertLink>
-      <Name lang="nl">Pudendusneuralgie</Name>
+      <Name lang="nl">Nervus pudendus-entrapmentsyndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -288203,7 +287642,45 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17546">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17547">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24621">
+            <Name lang="nl">Japan</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="15429">
           <Source>14517508[PMID]_31149222[PMID]</Source>
           <PrevalenceType id="23683">
@@ -292442,7 +291919,7 @@
     <Disorder id="11071">
       <OrphaCode>75326</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=75326</ExpertLink>
-      <Name lang="nl">Retinale arteriële tortuositeit</Name>
+      <Name lang="nl">Familiale geïsoleerde retinale arteriële tortuositeit</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -293984,7 +293461,7 @@
     <Disorder id="10453">
       <OrphaCode>39044</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=39044</ExpertLink>
-      <Name lang="nl">Uveamelanoom</Name>
+      <Name lang="nl">Melanoom van uvea</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -297148,7 +296625,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
         <Prevalence id="5542">
           <Source>Pr Ralph GRÄSBECK[EXPERT]</Source>
           <PrevalenceType id="23669">
@@ -297206,6 +296683,25 @@
             <Name lang="nl">Not yet validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17514">
+          <Source>Pr Ralph GRÄSBECK[EXPERT]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.5</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10405">
@@ -297744,6 +297240,38 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="10333">
+      <OrphaCode>34217</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=34217</ExpertLink>
+      <Name lang="nl">Ziekte van Naxos</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17476">
+          <Source>15210133[PMID]_34926342[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="10330">
       <OrphaCode>33577</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=33577</ExpertLink>
@@ -299116,7 +298644,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17552">
+          <Source>34626670[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>20.7</ValMoy>
+          <PrevalenceGeographic id="23949">
+            <Name lang="nl">Australia</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17059">
           <Source>34626670[PMID]</Source>
           <PrevalenceType id="23683">
@@ -299405,7 +298952,7 @@
     <Disorder id="10348">
       <OrphaCode>34587</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=34587</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte deficiëntie van LAMP-2</Name>
+      <Name lang="nl">Ziekte van Danon</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -301595,7 +301142,7 @@
     <Disorder id="10749">
       <OrphaCode>54251</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=54251</ExpertLink>
-      <Name lang="nl">Corticosteroïdesensitief aseptisch abces-syndroom</Name>
+      <Name lang="nl">Aseptisch abces-syndroom</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -301644,7 +301191,7 @@
     <Disorder id="27963">
       <OrphaCode>538931</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=538931</ExpertLink>
-      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door SH2D1A-deficiëntie</Name>
+      <Name lang="nl">X-gebonden lymfoproliferatieve ziekte door SAP-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -302689,7 +302236,7 @@
     <Disorder id="10630">
       <OrphaCode>48652</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=48652</ExpertLink>
-      <Name lang="nl">Monosomie 22q13.3</Name>
+      <Name lang="nl">Syndroom van Phelan-McDermid</Name>
       <DisorderType id="21401">
         <Name lang="nl">Malformatiesyndroom</Name>
       </DisorderType>
@@ -305577,7 +305124,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="6">
         <Prevalence id="5655">
           <Source>19170813[PMID]</Source>
           <PrevalenceType id="23676">
@@ -305635,6 +305182,63 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17534">
+          <Source>19170813[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.3</ValMoy>
+          <PrevalenceGeographic id="24418">
+            <Name lang="nl">Germany</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17535">
+          <Source>15569006[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.207</ValMoy>
+          <PrevalenceGeographic id="24677">
+            <Name lang="nl">Kuwait</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17536">
+          <Source>12207586[PMID]_23237497[PMID]_30252369[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.078</ValMoy>
+          <PrevalenceGeographic id="25244">
+            <Name lang="nl">Singapore</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="10596">
@@ -308296,7 +307900,7 @@
     <Disorder id="11925">
       <OrphaCode>90023</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=90023</ExpertLink>
-      <Name lang="nl">Primaire immuundeficiëntiesyndroom door LAMTOR2-deficiëntie</Name>
+      <Name lang="nl">Primair immuundeficiëntiesyndroom door P14/LAMTOR2-deficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -310040,7 +309644,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="10704">
           <Source>19289752[PMID]</Source>
           <PrevalenceType id="23676">
@@ -310060,6 +309664,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17553">
+          <Source>9918242[PMID]_19289752[PMID]_30658703[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.315</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11997">
@@ -313706,7 +313329,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11352">
           <Source>12769508[PMID]</Source>
           <PrevalenceType id="23683">
@@ -313726,6 +313349,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17564">
+          <Source>ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25468">
+            <Name lang="nl">United Arab Emirates</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="12212">
@@ -314768,7 +314410,7 @@
     <Disorder id="12259">
       <OrphaCode>93322</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93322</ExpertLink>
-      <Name lang="nl">Hemimelie van tibia</Name>
+      <Name lang="nl">Geïsoleerde hemimelie van tibia</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314819,7 +314461,7 @@
     <Disorder id="12258">
       <OrphaCode>93321</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93321</ExpertLink>
-      <Name lang="nl">Radiale hemimelie</Name>
+      <Name lang="nl">Geïsoleerde hemimelie van radius</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314870,7 +314512,7 @@
     <Disorder id="12257">
       <OrphaCode>93320</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93320</ExpertLink>
-      <Name lang="nl">Hemimelie van ulna</Name>
+      <Name lang="nl">Geïsoleerde hemimelie van ulna</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -314902,7 +314544,7 @@
     <Disorder id="12260">
       <OrphaCode>93323</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=93323</ExpertLink>
-      <Name lang="nl">Hemimelie van fibula</Name>
+      <Name lang="nl">Geïsoleerde hemimelie van fibula</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -315009,7 +314651,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17555">
+          <Source>31091006[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>43.5</ValMoy>
+          <PrevalenceGeographic id="24845">
+            <Name lang="nl">Mexico</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16278">
           <Source>31091006[PMID]</Source>
           <PrevalenceType id="23683">
@@ -315041,7 +314702,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17554">
+          <Source>31091006[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>15.7</ValMoy>
+          <PrevalenceGeographic id="24845">
+            <Name lang="nl">Mexico</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="16277">
           <Source>31091006[PMID]</Source>
           <PrevalenceType id="23683">
@@ -316160,7 +315840,64 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="6">
+        <Prevalence id="17531">
+          <Source>22966025[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="nl">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17532">
+          <Source>15858962[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24264">
+            <Name lang="nl">Denmark</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17533">
+          <Source>15466085[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14604">
           <Source>22966025[PMID]</Source>
           <PrevalenceType id="23683">
@@ -316262,7 +315999,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17568">
+          <Source>32021624[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="14607">
           <Source>17074786[PMID]</Source>
           <PrevalenceType id="23683">
@@ -319728,7 +319484,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="6521">
           <Source>31920360[PMID]</Source>
           <PrevalenceType id="23683">
@@ -319767,6 +319523,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17520">
+          <Source>31920360[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.963</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17541">
+          <Source>31920360[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2222</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11437">
@@ -321173,368 +320967,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="11290">
-      <OrphaCode>79264</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79264</ExpertLink>
-      <Name lang="nl">Juveniele neuronale ceroïdlipofuscinose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="10">
-        <Prevalence id="10746">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.46</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10747">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.2</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10748">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.22</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10749">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>4.8</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10750">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.65</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10751">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>3.7</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10752">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>1.1</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="nl">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10753">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>7.0</ValMoy>
-          <PrevalenceGeographic id="24551">
-            <Name lang="nl">Iceland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10754">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.31</ValMoy>
-          <PrevalenceGeographic id="24264">
-            <Name lang="nl">Denmark</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10755">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>2.0</ValMoy>
-          <PrevalenceGeographic id="24264">
-            <Name lang="nl">Denmark</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="11289">
-      <OrphaCode>79263</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79263</ExpertLink>
-      <Name lang="nl">Infantiele neuronale ceroïdlipofuscinose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="6">
-        <Prevalence id="6367">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10741">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.07</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10742">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.6</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10743">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.54</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10744">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23683">
-            <Name lang="nl">Geboorteprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>5.0</ValMoy>
-          <PrevalenceGeographic id="24362">
-            <Name lang="nl">Finland</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="10745">
-          <Source>9151309[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.02</ValMoy>
-          <PrevalenceGeographic id="25006">
-            <Name lang="nl">Norway</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
-    <Disorder id="11288">
-      <OrphaCode>79262</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79262</ExpertLink>
-      <Name lang="nl">Adulte neuronale ceroïdlipofuscinose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="6366">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23774">
-            <Name lang="nl">Unknown</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="11295">
       <OrphaCode>79269</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=79269</ExpertLink>
@@ -321876,7 +321308,45 @@
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17518">
+          <Source>32024337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17519">
+          <Source>32024337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>6.34</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="17122">
           <Source>32024337[PMID]</Source>
           <PrevalenceType id="23683">
@@ -330175,7 +329645,7 @@
     <Disorder id="11725">
       <OrphaCode>85458</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85458</ExpertLink>
-      <Name lang="nl">Erfelijke cerebrale hemorragie met amyloïdose</Name>
+      <Name lang="nl">Cerebrale amyloïdangiopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -330421,11 +329891,11 @@
       <OrphaCode>85447</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85447</ExpertLink>
       <Name lang="nl">ATTRV30M-amyloïdose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="8">
         <Prevalence id="6831">
@@ -330586,11 +330056,11 @@
       <OrphaCode>85451</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=85451</ExpertLink>
       <Name lang="nl">ATTRV122I-amyloïdose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
+      <DisorderType id="21450">
+        <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
+      <DisorderGroup id="36554">
+        <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
       <PrevalenceList count="1">
         <Prevalence id="6841">
@@ -330781,7 +330251,7 @@
     <Disorder id="11728">
       <OrphaCode>86789</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86789</ExpertLink>
-      <Name lang="nl">Patella-aplasie/hypoplasie</Name>
+      <Name lang="nl">Geïsoleerde aplasie/hypoplasie van patella</Name>
       <DisorderType id="21415">
         <Name lang="nl">Morfologische anomalie</Name>
       </DisorderType>
@@ -331303,7 +330773,7 @@
     <Disorder id="11749">
       <OrphaCode>86839</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=86839</ExpertLink>
-      <Name lang="nl">Refractaire anemie met overmaat aan blasten</Name>
+      <Name lang="nl">Myelodysplastisch neoplasma met overmaat aan blasten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -331883,7 +331353,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="11975">
           <Source>European Medicines Agency 2015[INST]</Source>
           <PrevalenceType id="23669">
@@ -331903,6 +331373,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17475">
+          <Source>36946176[PMID]</Source>
+          <PrevalenceType id="23676">
+            <Name lang="nl">Jaarlijkse incidentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.03</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="11765">
@@ -337046,6 +336535,136 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30613">
+      <OrphaCode>603448</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603448</ExpertLink>
+      <Name lang="nl">Cerebellaire hypoplasie - intellectuele achterstand - congenitale microcefalie - dystonie - anemie - groeiretardatie-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17486">
+          <Source>33186543[PMID]_33186545[PMID]_33460484[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>10.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17487">
+          <Source>33186543[PMID]_33186545[PMID]_33460484[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30615">
+      <OrphaCode>603515</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603515</ExpertLink>
+      <Name lang="nl">Geïsoleerde hypospadie bij vrouw</Name>
+      <DisorderType id="21415">
+        <Name lang="nl">Morfologische anomalie</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17490">
+          <Source>31105404[PMID]</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30614">
+      <OrphaCode>603494</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603494</ExpertLink>
+      <Name lang="nl">Coloboom - osteopetrose - microftalmie - macrocefalie - albinisme - doofheid-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17488">
+          <Source>27889061[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>2.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17489">
+          <Source>27889061[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="30617">
       <OrphaCode>603689</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=603689</ExpertLink>
@@ -337144,6 +336763,349 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30683">
+      <OrphaCode>610569</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=610569</ExpertLink>
+      <Name lang="nl">KIAA1109-gerelateerd vroeg-letale congenitale hersenmalformaties - artrogrypose-syndroom</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17499">
+          <Source>29290337[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17500">
+          <Source>29290337[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30663">
+      <OrphaCode>604680</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=604680</ExpertLink>
+      <Name lang="nl">Symptomatische vorm van X-gebonden centronucleaire myopathie bij vrouwelijke dragers</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17491">
+          <Source>28685322[PMID]_34011573[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>100.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17492">
+          <Source>28685322[PMID]_34011573[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30694">
+      <OrphaCode>611256</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=611256</ExpertLink>
+      <Name lang="nl">Pontocerebellaire hypoplasie type 12</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17507">
+          <Source>30089828[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17508">
+          <Source>30089828[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30692">
+      <OrphaCode>611237</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=611237</ExpertLink>
+      <Name lang="nl">Parkinsonisme met polyneuropathie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17501">
+          <Source>33141179[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>4.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17502">
+          <Source>33141179[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30693">
+      <OrphaCode>611247</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=611247</ExpertLink>
+      <Name lang="nl">Pontocerebellaire hypoplasie type 11</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17505">
+          <Source>28823707[PMID]_28823706[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>13.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17506">
+          <Source>28823707[PMID]_28823706[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30688">
+      <OrphaCode>611201</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=611201</ExpertLink>
+      <Name lang="nl">Oculogastro-intestinaal - neurologische ontwikkeling-syndroom</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17497">
+          <Source>32885237[PMID]_33410501[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>7.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17498">
+          <Source>32885237[PMID]_33410501[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="30702">
+      <OrphaCode>613267</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=613267</ExpertLink>
+      <Name lang="nl">Pontocerebellaire hypoplasie type 13</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17509">
+          <Source>30624672[PMID]_31207318[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>3.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17510">
+          <Source>30624672[PMID]_31207318[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13103">
       <OrphaCode>98085</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98085</ExpertLink>
@@ -337195,6 +337157,55 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="30703">
+      <OrphaCode>613274</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=613274</ExpertLink>
+      <Name lang="nl">Pontocerebellaire hypoplasie type 14</Name>
+      <DisorderType id="21401">
+        <Name lang="nl">Malformatiesyndroom</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="2">
+        <Prevalence id="17503">
+          <Source>33220177[PMID]</Source>
+          <PrevalenceType id="23697">
+            <Name lang="nl">Cases/families</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23718">
+            <Name lang="nl">Case</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass/>
+          <ValMoy>18.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17504">
+          <Source>33220177[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="13266">
       <OrphaCode>98249</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98249</ExpertLink>
@@ -339886,7 +339897,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17556">
+          <Source>9562017[PMID]_25752370[PMID]_34631807[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="24369">
+            <Name lang="nl">France</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13182">
           <Source>8308205[PMID]</Source>
           <PrevalenceType id="23683">
@@ -340658,7 +340688,7 @@
     <Disorder id="12860">
       <OrphaCode>97234</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=97234</ExpertLink>
-      <Name lang="nl">Glycogeenstapelingsziekte type 10</Name>
+      <Name lang="nl">Glycogeenstapelingsziekte door deficiëntie van fosfoglyceraatmutase</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -341325,7 +341355,26 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
+        <Prevalence id="17521">
+          <Source>20301604[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="13481">
           <Source>20301604[PMID]</Source>
           <PrevalenceType id="23683">
@@ -341712,7 +341761,7 @@
     <Disorder id="12650">
       <OrphaCode>95626</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95626</ExpertLink>
-      <Name lang="nl">Verworven centrale diabetes insipidus</Name>
+      <Name lang="nl">Verworven deficiëntie van arginine-vasopressine</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -342075,38 +342124,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="12581">
-      <OrphaCode>95161</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95161</ExpertLink>
-      <Name lang="nl">Chronische hepatische porfyrie</Name>
-      <DisorderType id="21436">
-        <Name lang="nl">Group of phenomes</Name>
-      </DisorderType>
-      <DisorderGroup id="36540">
-        <Name lang="nl">Groep van aandoeningen</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="7322">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23746">
-            <Name lang="nl">1-9 / 100 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23795">
-            <Name lang="nl">Europa</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="12580">
       <OrphaCode>95159</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=95159</ExpertLink>
@@ -344844,7 +344861,45 @@
       <DisorderGroup id="36554">
         <Name lang="nl">Subtype van aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
+        <Prevalence id="17544">
+          <Source>4250044[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23739">
+            <Name lang="nl">1-9 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.2</ValMoy>
+          <PrevalenceGeographic id="24124">
+            <Name lang="nl">Canada</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17545">
+          <Source>18796143[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23760">
+            <Name lang="nl">&lt;1 / 1 000 000</Name>
+          </PrevalenceClass>
+          <ValMoy>0.07</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
         <Prevalence id="12440">
           <Source>4250044[PMID]</Source>
           <PrevalenceType id="23683">
@@ -346085,8 +346140,8 @@
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
           </PrevalenceQualification>
           <PrevalenceClass id="23760">
             <Name lang="nl">&lt;1 / 1 000 000</Name>
@@ -348861,7 +348916,7 @@
     <Disorder id="29784">
       <OrphaCode>596759</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=596759</ExpertLink>
-      <Name lang="nl">Gecombineerde immuundeficiëntie door haplo-insufficiëntie van Rela</Name>
+      <Name lang="nl">Gecombineerde immuundeficiëntie door Rela-haploinsufficiëntie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -349468,7 +349523,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="2">
+      <PrevalenceList count="4">
         <Prevalence id="7778">
           <Source>18657826[PMID]</Source>
           <PrevalenceType id="23683">
@@ -349507,6 +349562,44 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17522">
+          <Source>12084585[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>9.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+        <Prevalence id="17542">
+          <Source>18657826[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
+          <ValMoy>8.0</ValMoy>
+          <PrevalenceGeographic id="25482">
+            <Name lang="nl">United States</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="14112">
@@ -349920,38 +350013,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14220">
-      <OrphaCode>99647</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99647</ExpertLink>
-      <Name lang="nl">Cheiro-spondylo-enchondromatose</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="1">
-        <Prevalence id="12060">
-          <Source>ORPHANET_20661403[PMID]</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25965">
-            <Name lang="nl">Not yet validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="14219">
       <OrphaCode>99646</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99646</ExpertLink>
@@ -350517,14 +350578,16 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16630">
-          <Source>PMID: 26882032</Source>
+          <Source>26882032[PMID]</Source>
           <PrevalenceType id="23669">
             <Name lang="nl">Puntprevalentie</Name>
           </PrevalenceType>
           <PrevalenceQualification id="23711">
             <Name lang="nl">Value and class</Name>
           </PrevalenceQualification>
-          <PrevalenceClass/>
+          <PrevalenceClass id="23746">
+            <Name lang="nl">1-9 / 100 000</Name>
+          </PrevalenceClass>
           <ValMoy>1.29</ValMoy>
           <PrevalenceGeographic id="24607">
             <Name lang="nl">Italy</Name>
@@ -352781,7 +352844,7 @@
     <Disorder id="13843">
       <OrphaCode>98826</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98826</ExpertLink>
-      <Name lang="nl">Refractaire anemia</Name>
+      <Name lang="nl">Myelodysplastisch neoplasma met weinig blasten</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -358914,7 +358977,7 @@
     <Disorder id="13925">
       <OrphaCode>98908</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98908</ExpertLink>
-      <Name lang="nl">Neutrale vetstapelingsmyopathie</Name>
+      <Name lang="nl">Neutrale vetstapelingsziekte met myopathie</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -359215,7 +359278,7 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="1">
+      <PrevalenceList count="2">
         <Prevalence id="7726">
           <Source>11826019[PMID]</Source>
           <PrevalenceType id="23683">
@@ -359235,6 +359298,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17557">
+          <Source>11826019[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23711">
+            <Name lang="nl">Value and class</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23732">
+            <Name lang="nl">1-5 / 10 000</Name>
+          </PrevalenceClass>
+          <ValMoy>19.0</ValMoy>
+          <PrevalenceGeographic id="25475">
+            <Name lang="nl">United Kingdom</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="13966">
@@ -360072,55 +360154,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="13992">
-      <OrphaCode>98975</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98975</ExpertLink>
-      <Name lang="nl">Congenitale hereditaire endotheliale dystrofie I</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="2">
-        <Prevalence id="7755">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23697">
-            <Name lang="nl">Cases/families</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23718">
-            <Name lang="nl">Case</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass/>
-          <ValMoy>68.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="7756">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23669">
-            <Name lang="nl">Puntprevalentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23704">
-            <Name lang="nl">Class only</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="13993">
       <OrphaCode>98976</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=98976</ExpertLink>
@@ -362514,9 +362547,9 @@
       <DisorderGroup id="36547">
         <Name lang="nl">Aandoening</Name>
       </DisorderGroup>
-      <PrevalenceList count="3">
+      <PrevalenceList count="4">
         <Prevalence id="16542">
-          <Source>PMID: 18720461; 25917534</Source>
+          <Source>18720461[PMID]_25917534[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -362535,7 +362568,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16543">
-          <Source>PMID: 25917534</Source>
+          <Source>25917534[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -362554,7 +362587,7 @@
           </PrevalenceValidationStatus>
         </Prevalence>
         <Prevalence id="16544">
-          <Source>PMID: 18720461</Source>
+          <Source>18720461[PMID]</Source>
           <PrevalenceType id="23676">
             <Name lang="nl">Jaarlijkse incidentie</Name>
           </PrevalenceType>
@@ -362572,6 +362605,25 @@
             <Name lang="nl">Validated</Name>
           </PrevalenceValidationStatus>
         </Prevalence>
+        <Prevalence id="17526">
+          <Source>18720461[PMID]_25917534[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23795">
+            <Name lang="nl">Europa</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
       </PrevalenceList>
     </Disorder>
     <Disorder id="13732">
@@ -367484,266 +367536,6 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
-    <Disorder id="14807">
-      <OrphaCode>101096</OrphaCode>
-      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101096</ExpertLink>
-      <Name lang="nl">Aregeneratieve anemie</Name>
-      <DisorderType id="21394">
-        <Name lang="nl">Ziekte</Name>
-      </DisorderType>
-      <DisorderGroup id="36547">
-        <Name lang="nl">Aandoening</Name>
-      </DisorderGroup>
-      <PrevalenceList count="13">
-        <Prevalence id="16820">
-          <Source>ORPHANET</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.3312</ValMoy>
-          <PrevalenceGeographic id="23844">
-            <Name lang="nl">Wereldwijd</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16821">
-          <Source>2183887[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.15</ValMoy>
-          <PrevalenceGeographic id="24369">
-            <Name lang="nl">France</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16822">
-          <Source>18322256[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.234</ValMoy>
-          <PrevalenceGeographic id="25293">
-            <Name lang="nl">Spain</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16823">
-          <Source>28751565[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.235</ValMoy>
-          <PrevalenceGeographic id="25335">
-            <Name lang="nl">Sweden</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16824">
-          <Source>1813058[PMID]_31091521[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.535</ValMoy>
-          <PrevalenceGeographic id="24166">
-            <Name lang="nl">China</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16825">
-          <Source>30178191[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.567</ValMoy>
-          <PrevalenceGeographic id="25356">
-            <Name lang="nl">Taiwan, Province of China</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16826">
-          <Source>10398308[PMID]_34269837[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.425</ValMoy>
-          <PrevalenceGeographic id="25377">
-            <Name lang="nl">Thailand</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16827">
-          <Source>10968139[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.48</ValMoy>
-          <PrevalenceGeographic id="24782">
-            <Name lang="nl">Malaysia</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16828">
-          <Source>31906834[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.35</ValMoy>
-          <PrevalenceGeographic id="25020">
-            <Name lang="nl">Pakistan</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16829">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.119</ValMoy>
-          <PrevalenceGeographic id="23928">
-            <Name lang="nl">Argentina</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16830">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.217</ValMoy>
-          <PrevalenceGeographic id="24068">
-            <Name lang="nl">Brazil</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16831">
-          <Source>19734415[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23760">
-            <Name lang="nl">&lt;1 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.0063</ValMoy>
-          <PrevalenceGeographic id="24845">
-            <Name lang="nl">Mexico</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-        <Prevalence id="16832">
-          <Source>30592075[PMID]</Source>
-          <PrevalenceType id="23676">
-            <Name lang="nl">Jaarlijkse incidentie</Name>
-          </PrevalenceType>
-          <PrevalenceQualification id="23711">
-            <Name lang="nl">Value and class</Name>
-          </PrevalenceQualification>
-          <PrevalenceClass id="23739">
-            <Name lang="nl">1-9 / 1 000 000</Name>
-          </PrevalenceClass>
-          <ValMoy>0.6</ValMoy>
-          <PrevalenceGeographic id="25370">
-            <Name lang="nl">Tanzania, United Republic of</Name>
-          </PrevalenceGeographic>
-          <PrevalenceValidationStatus id="25958">
-            <Name lang="nl">Validated</Name>
-          </PrevalenceValidationStatus>
-        </Prevalence>
-      </PrevalenceList>
-    </Disorder>
     <Disorder id="14752">
       <OrphaCode>101041</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=101041</ExpertLink>
@@ -370398,7 +370190,7 @@
     <Disorder id="14593">
       <OrphaCode>100020</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100020</ExpertLink>
-      <Name lang="nl">Refractaire anemie met exces aan blasten type 2</Name>
+      <Name lang="nl">Myelodysplastisch neoplasma met overmaat aan blasten type 2</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -370430,7 +370222,7 @@
     <Disorder id="14592">
       <OrphaCode>100019</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=100019</ExpertLink>
-      <Name lang="nl">Refractaire anemie met exces aan blasten type 1</Name>
+      <Name lang="nl">Myelodysplastisch neoplasma met overmaat aan blasten type 1</Name>
       <DisorderType id="21450">
         <Name lang="nl">Klinisch subtype</Name>
       </DisorderType>
@@ -373855,7 +373647,7 @@
     <Disorder id="14485">
       <OrphaCode>99912</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=99912</ExpertLink>
-      <Name lang="nl">Maligne dysgerminomateuze kiemceltumor van ovarium</Name>
+      <Name lang="nl">Dysgerminoom van ovarium</Name>
       <DisorderType id="21394">
         <Name lang="nl">Ziekte</Name>
       </DisorderType>
@@ -376347,6 +376139,70 @@
         </Prevalence>
       </PrevalenceList>
     </Disorder>
+    <Disorder id="31322">
+      <OrphaCode>615970</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=615970</ExpertLink>
+      <Name lang="nl">Chronische intervillositis met onbekende etiologie</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17494">
+          <Source>32841927[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
+    <Disorder id="31346">
+      <OrphaCode>617408</OrphaCode>
+      <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=617408</ExpertLink>
+      <Name lang="nl">Klassieke eosinofiele pustulaire folliculitis</Name>
+      <DisorderType id="21394">
+        <Name lang="nl">Ziekte</Name>
+      </DisorderType>
+      <DisorderGroup id="36547">
+        <Name lang="nl">Aandoening</Name>
+      </DisorderGroup>
+      <PrevalenceList count="1">
+        <Prevalence id="17493">
+          <Source>37983361[PMID]_ORPHANET</Source>
+          <PrevalenceType id="23669">
+            <Name lang="nl">Puntprevalentie</Name>
+          </PrevalenceType>
+          <PrevalenceQualification id="23704">
+            <Name lang="nl">Class only</Name>
+          </PrevalenceQualification>
+          <PrevalenceClass id="23774">
+            <Name lang="nl">Unknown</Name>
+          </PrevalenceClass>
+          <ValMoy>0.0</ValMoy>
+          <PrevalenceGeographic id="23844">
+            <Name lang="nl">Wereldwijd</Name>
+          </PrevalenceGeographic>
+          <PrevalenceValidationStatus id="25958">
+            <Name lang="nl">Validated</Name>
+          </PrevalenceValidationStatus>
+        </Prevalence>
+      </PrevalenceList>
+    </Disorder>
     <Disorder id="31468">
       <OrphaCode>623789</OrphaCode>
       <ExpertLink lang="nl">http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=nl&amp;Expert=623789</ExpertLink>
